CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 956 enrolled
Drug / intervention
GreenLight XPS Laser Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02139969
NCT02139969N/ACompleted
CompareCT.gov

GreenLight XPS Laser System for the Treatment of Benign Prostatic Hyperplasia: Evaluation of Safety, Efficacy, and Quality of Life Through Retrospective Chart Review

Boston Scientific Corporation·observational·Posted May 16, 2014·Updated Nov 9, 2020

In Brief

An observational study evaluating GreenLight XPS Laser System for Benign Prostatic Hyperplasia. Completed, enrolled 956 participants across 6 sites in 2 countries.

Detailed Summary

The purpose of this study is to gain information on the safety, efficacy, and quality of life in subjects who have had the GreenLight XPS procedure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 16, 2014
Enrollment StartMay 1, 2014
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 12.1 years ago

Interventions

GreenLight XPS Laser Systemdevice